Surgery-Based Salvage for Locoregional Recurrent Salivary Gland Carcinoma: Comparative Survival Evidence from a Systematic Review and Meta-analysis
Objectives.: To compare survival outcomes between surgery-based salvage and non-surgical management in patients with locoregional recurrent salivary gland carcinoma (RSGC), and to explore whether surgery-based salvage is associated with more favorable outcomes in appropriately selected patients. Methods.: A search was performed in MEDLINE (Ovid), EMBASE, and the Cochrane Library. Observational studies were included that reported comparative outcomes for surgery-based salvage (resection ± adjuvant therapy) versus non-surgical management (re-irradiation, brachytherapy, systemic therapy, or palliative treatment) in locoregional recurrent disease. Patients with distant metastasis at recurrence were excluded from the pooled analysis. Primary outcomes were overall survival (OS) and disease-free survival (DFS). Hazard ratios (HRs) were calculated as non-surgical management versus surgery-based salvage and pooled using a random-effects model. Risk of bias was assessed using RoBANS 2.0. Results.: Five retrospective comparative studies (N = 163) met the inclusion criteria. Four studies contributed to a meta-analysis for OS (N = 153) and DFS (N = 145). In pooled observational analyses, non-surgical management showed higher hazard estimates for OS (pooled HR = 3.40; 95% confidence interval [CI], 1.17-9.84; p = 0.024) and DFS (pooled HR = 3.09; 95% CI, 1.21-7.91; p = 0.019) than surgery-based salvage. Heterogeneity was considerable for OS (I² = 80.1%) and moderate for DFS (I² = 56.4%). Most studies had moderate-to-high risk of bias, particularly for participant comparability and residual confounding. Conclusion.: Available comparative observational evidence suggests that surgery-based salvage may be associated with more favorable survival outcomes in appropriately selected patients with locoregional RSGC. However, the evidence base is small, retrospective, and clinically heterogeneous; therefore, these findings should be interpreted as exploratory rather than confirmatory, and treatment decisions should be individualized within a multidisciplinary approach.
Authors
- Gene Huh (ORCID: https://orcid.org/0000-0003-4487-1361)
- Jeon Yeob Jang (ORCID: https://orcid.org/0000-0002-9047-4896)
- Geun‐Jeon Kim
- Jooin Bang (ORCID: https://orcid.org/0000-0002-2525-5144)
- Jeong Wook Kang (ORCID: https://orcid.org/0000-0002-0305-1255)
- Heejin Kim
- Sung Joon Park
- Soon-Hyun Ahn
- Ji Won Kim
- Jeong-Yeon Ji
- Eun-Jae Chung
Institutions
- Seoul National University (KR)
- Chungnam National University (KR)
- Seoul Metropolitan Government (KR)
- Seoul National University Hospital (KR)
- Seoul National University Bundang Hospital (KR)
- SNUH SMG-SNU Boramae Medical Center (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- Chung-Ang University Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
- Ajou University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Clinical and Experimental Otorhinolaryngology
- Published
- 2026-05-29
- DOI
- https://doi.org/10.21053/ceo.2026-00056
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00